Horizon Pharma Pays $145 Million For And Its Rare Eye Disease Drug Post author:Sam Post published:May 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Ultragenyx Stock Booms After Burosumab Continues to Impress in Phase III Study December 3, 2017 Biotech Vets Launch With $38 Million and Will be Helmed By Biogen Alum February 26, 2017 Iovance Biotherapeutics Partners With TrakCel For Personalized Patient Product Management September 10, 2017
Iovance Biotherapeutics Partners With TrakCel For Personalized Patient Product Management September 10, 2017